Martin Vogelbaum is the founder of Ajax Therapeutics. Ajax Therapeutics has raised $135M, latest Series C $95M (2024). Biotech · New York, NY.
Martin Vogelbaum is the founder of Ajax Therapeutics. Ajax Therapeutics operates in Biotech and is based in New York, NY. Ajax Therapeutics has raised $135M, latest Series C $95M (2024). Backers on record include Oleg Nodelman, Shan Fu, EcoR1 Capital, Vivo Capital.
This founder profile draws on disclosed rounds, filings and investor records in the StartupFundraising database and is updated as new funding is recorded. Founders raising now use profiles like this one to study comparable Biotech journeys in New York — who backed them, at what stage, and how much they raised.
Full founder directory · Investor directory · Company funding database · Fundraising library